KPL-1Homo sapiens (Human)Cancer cell line

Also known as: KPL1, KPL.1

🤖 AI SummaryBased on 11 publications

Quick Overview

Human breast cancer cell line with tumorigenic properties.

Detailed Summary

KPL-1 is a human breast cancer cell line established from the malignant pleural effusion of a patient with recurrent breast cancer. It exhibits high tumorigenicity and grows rapidly in female athymic nude mice. The cell line shows a hypertriploid karyotype with 74-80 chromosomes, indicating significant chromosomal instability. KPL-1 cells express epithelial markers such as cytokeratin and carcinobromin, as well as the tumor-associated antigens CA 15-3 and tissue polypeptide antigen (TPA). They also possess a high number of estrogen receptors but lack progesterone receptors. Notably, KPL-1 cells secrete large amounts of TPA, which correlates with tumor volume both in vivo and in vitro. The cell line does not show amplification of c-erbB-2, c-myc, H-ras, or N-ras genes, suggesting a distinct genetic profile compared to other breast cancer cell lines. KPL-1 is useful for studying breast cancer biology and for evaluating therapeutic agents due to its rapid growth and tumorigenic properties.

Research Applications

Tumor biology studiesDrug screeningTumor-associated antigen analysis

Key Characteristics

High tumorigenicity in nude miceHypertriploid karyotypeExpression of epithelial markersHigh estrogen receptor expressionSecretion of TPA and CA 15-3
Generated on 6/18/2025

Basic Information

Database IDCVCL_2094
SpeciesHomo sapiens (Human)
Tissue SourcePleural effusion[UBERON:UBERON_0000175]

Donor Information

Age69
Age CategoryAdult
SexFemale
Racecaucasian
Subtype FeaturesER+

Disease Information

DiseaseInvasive breast carcinoma of no special type
LineageBreast
SubtypeInvasive Breast Carcinoma
OncoTree CodeBRCA

DepMap Information

Source TypeDSMZ
Source IDACH-000028_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimplePIK3CAp.Glu545Lys (c.1633G>A)Heterozygous-from parent cell line MCF-7
MutationSimpleGATA3p.Asp336Glyfs*17 (c.1006dupG)Heterozygous-from parent cell line MCF-7
Gene deletionCDKN2A-HomozygousPossiblePubMed=26870271

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10
D13S317
10,11
D16S539
11,12
D18S51
14
D19S433
13,14
D21S11
30
D2S1338
21,23
D3S1358
16
D5S818
11,12
D7S820
8,9
D8S1179
10,14
FGA
23,25
Penta D
12
Penta E
7,12
TH01
6
TPOX
9,12
vWA
14,15
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Quantitative proteomics of the Cancer Cell Line Encyclopedia.";

Sellers W.R., Gygi S.P.

Cell 180:387-402.e16(2020).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Multidimensional phenotyping of breast cancer cell lines to guide preclinical research.

Lakhani S.R.

Breast Cancer Res. Treat. 167:289-301(2018).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

Essential gene profiles in breast, pancreatic, and ovarian cancer cells.

Rottapel R., Neel B.G., Moffat J.

Cancer Discov. 2:172-189(2012).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Check your cultures! A list of cross-contaminated or misidentified cell lines.

Freshney R.I.

Int. J. Cancer 127:1-8(2010).

SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines.

Garraway L.A., Rubin M.A.

Nucleic Acids Res. 36:2446-2456(2008).

Molecular characterization of breast cancer cell lines by a low-density microarray.

Remacle J.

Int. J. Oncol. 27:881-892(2005).

Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays.

Yamori T.

Mol. Cancer Ther. 4:399-412(2005).

Evidence that both genetic instability and selection contribute to the accumulation of chromosome alterations in cancer.

Edwards P.A.W., Caldas C.

Carcinogenesis 26:923-930(2005).

Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data.

Gooden G.C., Ethier S.P., Kallioniemi A.H., Kallioniemi O.-P.

Cancer Res. 60:4519-4525(2000).

A new human breast cancer cell line, KPL-1 secretes tumour-associated antigens and grows rapidly in female athymic nude mice.

Kurebayashi J., Kurosumi M., Sonoo H.

Br. J. Cancer 71:845-853(1995).

Breast cancer stem cells: tumourspheres and implications for therapy.";

Morrison B.J.

Thesis PhD (2010); Griffith University; Brisbane; Australia.